References
- Huh WK , AultKA, ChelmowDet al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol. Oncol.136, 178–182 (2015).
- Thrall M , KjeldahlK, GulbahceHE, PambuccianSE. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas. Cancer111, 217–223 (2007).
- Bakkum-Gamez JN , WentzensenN, MaurerMJet al. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol. Oncol.137, 14–22 (2015).
- Kinde I , BettegowdaC, WangYet al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci. Transl. Med.5, 167ra4 (2013).
- Finan M , PannellL, BillheimerD, SchambeauL, BlandfordJ, RocconiR. A novel method of screening for endometrial cancer. Gynecol. Oncol.125(Suppl. 1), S165 (2012).
- Fiegl H GC , WidschwendterA, SchneitterAet al. Methylated DNA collected by tampons – a new tool to detect endometrial cancer. Cancer Epidemiol. Biomarkers Prev.13, 882–888 (2004).
- Erickson BK , KindeI, DobbinZCet al. Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer. Obstet. Gynecol.124, 881–885 (2014).
- Properzi F , LogozziM, FaisS. Exosomes: the future of biomarkers in medicine. Biomark. Med.7, 769–778 (2013).
- Wentzensen N , Bakkum-GamezJN, KillianJKet al. Discovery and validation of methylation markers for endometrial cancer. Int. J. Cancer135, 1860–1868 (2014).
- Dood RL , GraciaCR, SammelMD, HaynesK, SenapatiS, StromBL. Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding. J. Minim. Invasive Gynecol.21, 744–752 (2014).
- Khan AM , SasieniP, SingerA. A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses. BJOG122, 388–394 (2015).
- Rocconi RP , ScaliciJM, BillheimerDet al. Early detection of ovarian cancer via a self-sampling screening test of vaginal secretions: feasibility and patient acceptance. Gynecol. Oncol.137(Suppl. 1), 172–173 (2015).
- Arbyn M , VerdoodtF, SnijdersPJFet al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol.15, 172–183 (2014).
- Imperiale TF , RansohoffDF, ItzkowitzSHet al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med.370, 1287–1297 (2014).
- Cheng WF , ChenYL, YouSLet al. Risk of gynaecological malignancies in cytologically atypical glandular cells: follow-up study of a nationwide screening population. BJOG118, 34–41 (2011).